期刊文献+

阿替普酶 尿激酶治疗急性心肌梗死88例临床分析 被引量:5

下载PDF
导出
摘要 在目前医疗条件下,静脉溶栓仍是治疗急性心肌梗死的重要方法。阿替普酶(rt-PA)、尿激酶是目前国内常用的溶栓药物,为探讨其疗效及不良反应进行该研究,现报告如下。
作者 燕芳
出处 《实用医技杂志》 2012年第12期1317-1318,共2页 Journal of Practical Medical Techniques
  • 相关文献

参考文献2

二级参考文献21

  • 1杨艳敏,朱俊,谭慧琼,梁岩,章晏,李建东,刘力生,CREATE中国课题组.中国ST段抬高的急性心肌梗死临床特征及治疗现状[J].中华医学杂志,2005,85(31):2176-2182. 被引量:86
  • 2Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 3Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet,1996, 21:771-775.
  • 4Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coil Cardiol,2004 ,44 :671-719.
  • 5Wang TY, Peterson ED, Ou FS, et al. Door-to-balloon times for patients with ST-segment elevation myocardial infarction requiring interhospital transfer for primary percutaneous coronary intervention: a report from the national cardiovascular data registry. Am Heart J,2011,161:76-83.
  • 6Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol,2003 ,92 :824-826.
  • 7Assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention (ASSENT-4 PCI ) investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI) :randomised trial. Lancet, 2006,367:569-578.
  • 8Ellis SG, Tendera M, de Belder MA, et al. 1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE ( facilitated intervention with enhanced reperfusion speed to stop events) trial. JACC Cardiovasc Interv,2009 ,2 :909-916.
  • 9Borgia F, Goodman SG, Halvorsen S, et al, Early routine pereutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a rneta-analysis. Eur Heart J,2010,31:2156-2169.
  • 10D'Souza SP, Mamas MA, Fraser DG, et al. Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta- analysis. Eur Heart J, 2011,32:972-982.

共引文献2012

同被引文献34

  • 1林俊亮.用阿替普酶为急性心肌梗死患者进行溶栓治疗的效果观察[J].当代医药论丛,2014,12(9):224-226. 被引量:4
  • 2王树源,崔翠萍.急性心肌梗死并发右束支传导阻滞25例临床分析[J].热带医学杂志,2006,6(5):559-560. 被引量:18
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33041
  • 4Madias JE. Performance of the high-sensitivity troponin assay in diagno- sing? acute myocardial itffarction:systematic review and meta-analysis [ J ]. CMAJ Open ,2014,2 ( 3 ) : E199-E207.
  • 5周俐欣.不典型急性心肌梗死临床诊治分析[J].中国保健营养(中旬刊),2012,(11):452-452.
  • 6吐地海尼木·阿布都热依木.分析急性心肌梗死溶栓治疗中尿激酶与阿替普酶应用的价值[J].健康之路,2014,(3):150-150.
  • 7Shanna V, Bell RM, Yellon DM. Targeting reperfusion injury in acute mycardial infarction: a review of reperfusion injury pharmacotherapy [ J]. Expert Opin Phamacother,2012,13 ( 8 ) : 1153-1175.
  • 8Rosa GM, Bauckneht M, Ferrero S, et al. Acute myocardial infarction in pregnancy [ J ]. G Ital Cardiol (Rome) ,2013,14 (2) : 126-1 34.
  • 9Eagle KA, Nallamothu BK, Mehta RH, et al. Trends in acute reperfu- sion therapy for STEMI from 1999 to 2006 [ J ]. Eur Heart J,2008,29 (5) :609-617.
  • 10Boudreau DM, Guzauskas GF, Chen E, et al. Cost-Effectiveness of re- combinant Tissue-Type plasminogen activator within 3 hours of acute is- chemic stroke current evidence [ J ]. Stroke,2014,45 ( 10 ) :3032-3039.

引证文献5

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部